BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 26324276)

  • 1. Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda.
    Smith KD; Achan B; Hullsiek KH; McDonald TR; Okagaki LH; Alhadab AA; Akampurira A; Rhein JR; Meya DB; Boulware DR; Nielsen K;
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7197-204. PubMed ID: 26324276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
    Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade.
    Naicker SD; Mpembe RS; Maphanga TG; Zulu TG; Desanto D; Wadula J; Mvelase N; Maluleka C; Reddy K; Dawood H; Maloba M; Govender NP;
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008137. PubMed ID: 32231354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
    Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A
    Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease.
    Nascimento E; Vitali LH; Kress MRVZ; Martinez R
    Rev Inst Med Trop Sao Paulo; 2017; 59():e49. PubMed ID: 28793019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.
    Nielsen K; Vedula P; Smith KD; Meya DB; Garvey EP; Hoekstra WJ; Schotzinger RJ; Boulware DR
    Med Mycol; 2017 Jun; 55(4):453-456. PubMed ID: 27664991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
    Khyriem AB; Sujatha S; Parija SC
    Indian J Pathol Microbiol; 2006 Apr; 49(2):307-8. PubMed ID: 16933750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
    Córdoba S; Isla MG; Szusz W; Vivot W; Altamirano R; Davel G
    Mycoses; 2016 Jun; 59(6):351-6. PubMed ID: 26865081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans.
    Hai TP; Van AD; Ngan NTT; Nhat LTH; Lan NPH; Vinh Chau NV; Thwaites GE; Krysan D; Day JN
    Mycoses; 2019 Sep; 62(9):818-825. PubMed ID: 31173410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
    Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY
    Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
    Loyse A; Burry J; Cohn J; Ford N; Chiller T; Ribeiro I; Koulla-Shiro S; Mghamba J; Ramadhani A; Nyirenda R; Aliyu SH; Wilson D; Le T; Oladele R; Lesikari S; Muzoora C; Kalata N; Temfack E; Mapoure Y; Sini V; Chanda D; Shimwela M; Lakhi S; Ngoma J; Gondwe-Chunda L; Perfect C; Shroufi A; Andrieux-Meyer I; Chan A; Schutz C; Hosseinipour M; Van der Horst C; Klausner JD; Boulware DR; Heyderman R; Lalloo D; Day J; Jarvis JN; Rodrigues M; Jaffar S; Denning D; Migone C; Doherty M; Lortholary O; Dromer F; Stack M; Molloy SF; Bicanic T; van Oosterhout J; Mwaba P; Kanyama C; Kouanfack C; Mfinanga S; Govender N; Harrison TS
    Lancet Infect Dis; 2019 Apr; 19(4):e143-e147. PubMed ID: 30344084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcus neoformans var neoformans resistant to fluconazole in an HIV-negative patient with chronic lymphocytic leukemia.
    Assing K; Birgens H; Arendrup M
    Clin Microbiol Infect; 2003 May; 9(5):441-4. PubMed ID: 12848761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current approach to the acute management of cryptococcal infections.
    Powderly WG
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract]   [Full Text] [Related]  

  • 16. Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole.
    Kammalac Ngouana T; Dongtsa J; Kouanfack C; Tonfack C; Fomena S; Mallié M; Delaporte E; Boyom FF; Bertout S
    J Mycol Med; 2015 Mar; 25(1):11-6. PubMed ID: 25467817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002.
    Sar B; Monchy D; Vann M; Keo C; Sarthou JL; Buisson Y
    J Antimicrob Chemother; 2004 Aug; 54(2):563-5. PubMed ID: 15254027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species.
    Bongomin F; Oladele RO; Gago S; Moore CB; Richardson MD
    Mycoses; 2018 May; 61(5):290-297. PubMed ID: 29377368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcal meningitis in AIDS.
    Iyer RS; Banker DD
    Indian J Med Sci; 2002 Dec; 56(12):593-7. PubMed ID: 14514241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole-resistant cryptococcal meningitis.
    Momoff N; Parrish A
    S Afr Med J; 2003 Jun; 93(6):444. PubMed ID: 12916384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.